| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.04 |
—
|
| 2025 | 0.15 |
—
—
|
| 2024 | 0.13 |
—
—
|
| 2023 | 0.13 |
—
—
|
| 2022 | 0.13 |
—
—
|
| 2021 | 0.19 |
—
—
|
| 2020 | ‡‡‡‡‡ |
|
| 2019 | 0.13 |
—
—
|
| 2018 | 0.12 |
—
—
|
| 2017 | 0.10 |
—
—
|
| 2016 | 0.08 |
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 328.11 | 548.95 | 655.92 | 747.26 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 328.11 | 548.95 | 655.92 | 747.26 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | — | — | — | — |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 34.42 | 12.10 | 60.03 | 78.18 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1,720.37) | 110.68 | — | — |
—
|
| ’25 | 118.86 | 191.29 | 69.80 | 33.41 |
413.36
|
| ’24 | 44.30 | 159.65 | 249.11 | 93.03 |
546.09
|
| ’23 | 380.91 | 44.55 | 368.87 | 292.57 |
1,086.90
|
| ’22 | 123.10 | 32.15 | (12.70) | 161.34 |
319.23
|
| ’21 | — | 72.98 | — | — |
217.33
|
| ’20 | — | 182.27 | — | 25.34 |
359.12
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (136.63) | 51.98 | — | — |
—
|
| ’25 | 155.17 | (84.23) | (20.05) | (79.90) |
(29.01)
|
| ’24 | 52.96 | (97.38) | 279.80 | (18.66) |
216.73
|
| ’23 | (16.09) | (203.77) | 15.61 | (70.43) |
(274.68)
|
| ’22 | (52.38) | (88.40) | (53.81) | (271.52) |
(466.10)
|
| ’21 | — | 122.34 | — | (585.36) |
(585.36)
|
| ’20 | — | (45.16) | — | 53.83 |
53.83
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (136.67) | 51.93 | — | — |
—
|
| ’25 | 155.15 | (84.33) | (20.11) | (80.00) |
(29.30)
|
| ’24 | 52.92 | (97.42) | 279.75 | (19.18) |
216.06
|
| ’23 | (16.81) | (206.02) | 15.62 | (70.69) |
(277.89)
|
| ’22 | (52.42) | (88.41) | (53.93) | (271.75) |
(466.51)
|
| ’21 | — | 122.34 | — | (585.65) |
(585.65)
|
| ’20 | — | (45.16) | — | 53.47 |
53.47
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (7.46) | 0.01 | — | — |
—
|
| ’25 | 0.14 | 0.39 | (0.09) | (0.17) |
0.28
|
| ’24 | (0.14) | 0.24 | 0.61 | (0.06) |
0.66
|
| ’23 | 1.17 | (0.10) | 1.22 | 0.45 |
2.74
|
| ’22 | — | (0.10) | — | 0.24 |
0.14
|
| ’21 | — | (0.31) | — | — |
(0.33)
|
| ’20 | — | 0.68 | — | 0.10 |
0.78
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | ‡‡‡‡ | ‡‡‡ | 6.94 | 6.09 | 12.07 | 8.19 | — | — | — |
Low Price
|
| — | — | — | — | ‡‡‡‡ | ‡‡‡‡‡ | 11.20 | 17.70 | 16.77 | 15.73 | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡‡‡ | 158 | 16 | 160 | 172 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 2.02 | 67.93 | 3.41 | 2.40 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 319.23 | 1,086.90 | 546.09 | 413.36 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 109.02 | 738.28 | 253.59 | 84.03 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.15% | 67.93% | 46.44% | 20.33% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 97.46 | 718.20 | 229.58 | 72.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.36 | 5.53 | — | — | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.46 | 4.97 | 2.49 | 1.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.14 | 2.79 | 0.66 | 0.28 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.13) | (1.25) | 0.99 | (0.13) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (0.01) | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.13) | (1.27) | 0.99 | (0.13) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.91 | 14.66 | 14.86 | 14.27 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 218.76 | 218.87 | 219.23 | 219.15 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 5.41 | 19.03 | 31.86 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.01 | 3.04 | 5.12 | 4.73 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.77 | 1.03 | 0.86 | 0.63 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.34 | 4.15 | 7.35 | 8.30 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.08) | (16.24) | 18.57 | (117.04) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (466.10) | (274.68) | 216.73 | (29.01) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.41) | (3.21) | (0.66) | (0.28) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (466.51) | (277.89) | 216.06 | (29.30) | — | — | — |
FCF
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 227.20 | 293.69 | 536.85 | 595.89 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,254.68 | 1,534.73 | 1,763.61 | 2,127.83 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,010.66 | 1,206.62 | 1,214.66 | 1,471.91 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,387.07 | 3,207.78 | 3,256.84 | 3,127.73 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.76% | 12.06% | 2.44% | 0.98% | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.59% | 11.55% | 5.46% | 3.15% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.36% | 21.82% | 4.53% | 1.96% | — | — | — |
ROE
|
Burford Capital (BUR) exemplifies the high-upside potential of litigation finance, a scalable asset class with lumpy but transformative realizations. Revenues surged 241% to $1.087 billion in 2023 on the YPF Argentina win, dipped 50% to $546 million in 2024 amid expected volatility, yet remain 71% above pre-2023 levels. Forecasts signal robust growth: $708 million (+30%) in 2025, $925 million (+31%) in 2026, and $1.059 billion (+14%) in 2027, driving EPS from $0.66 to $2.27—a 244% compound rise. Trading at a 0.86x P/B discount to book value and forward P/E compressing to 6x by 2027, BUR screams undervaluation versus its efficiency (100% gross margins, ROE peaking at 21.8%).
Profitability shines through capital leverage: net income rebounded to forecasts of $516 million by 2027, with positive FCF ($0.99/share in 2024) fueling deployments without dilution. Book value per share compounded 71% since 2020 to $14.86, bolstered by a resilient balance sheet (net debt $1.21 billion vs. $3.26 billion equity). Insider conviction via a key officer’s $335k buy near lows offsets sell noise, while analyst consensus targets imply 107% average upside (70-160% range), tied to a diversified pipeline amid global dispute backlogs.
BUR’s trajectory positions it for dominance, with ROE north of 19% and revenues hitting $1B+ annually by 2027—mirroring 15x revenue multiples for early entrants. Despite case risks, statistical diversification and metrics like 11.6% ROIC de-risk the flywheel, setting up explosive catch-up from 47% below 2023 highs. Dive into the full analysis for the quant models and probability breakdowns.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.